Shares of Moderna jumped 5.12% to $187.97 at 12:24 EST on Monday, following the last session’s upward trend. NASDAQ Composite is falling 0.26% to $13,925.82, following the last session’s downward trend, This seems, so far, a somewhat rough trend exchanging session today.
Moderna’s last close was $178.82, 0.69% under its 52-week high of $189.26.
News about Moderna today
Moderna to supply up to 500 million vaccine doses to covax. According to today’s article on Bloomberg Quint, "The terms of the agreement with Gavi weren’t disclosed, though Moderna said it’s offering the vaccine at the company’s "lowest-tiered price.", "Rich countries last year snapped up vaccine supplies from Moderna and others, and the U.S. alone has already administered more than 240 million doses. "
Moderna to supply 500 million Covid-19 vaccine doses on behalf of covax. According to today’s article on MarketWatch, "We recognize that many countries have limited resources to access COVID-19 vaccines," said Moderna Chief Executive Stéphane Bancel. "
Moderna to deliver Covid-19 vaccine to hard-hit developing world. According to today’s article on The Wall Street Journal, "Covax will retain an option to purchase another 466 million doses in 2022, according to a statement by Moderna and Gavi, one of the organizations behind the vaccine aid program."
Moderna’s sales growth is 24182.2% for the present quarter and 6321.4% for the next. The company’s growth estimates for the present quarter and the next is 782.9% and 1983.9%, respectively.
Year-on-year quarterly revenue growth grew by 3960.8%, now sitting on 803.4M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $187.97 at 12:24 EST, under its 52-week high of $189.26 and way above its 52-week low of $30.98.
Moderna’s Moving Average
Moderna’s value is way above its 50-day moving average of $143.54 and way above its 200-day moving average of $119.02.
Previous days news about Moderna
Japan to approve Moderna vaccine as soon as May 21, yomiuri says. According to Bloomberg Quint on Saturday, 1 May, "The Moderna vaccine would be the second to get approved in Japan and will be used in the nation’s large inoculation centers that will open in Tokyo and Osaka from May 24, the paper said. ", "Japan has a contract with Moderna for enough shots to inoculate 25 million people, and is set to receive sufficient deliveries for 20 million by June and another 5 million in the following three months, the paper said."
More news about Moderna.